Discounts on expensive hepatitis C drugs could be within reach for half the country because the pharmacy benefit manager that negotiated discounts on hepatitis C drugs for Missouri is linked to Medicaid plans across America. And with drug companies coming to the negotiating table for hepatitis C, Medicaid plans could have luck negotiating over expensive new biologics that treat cancer, PCSK-9 inhibitors that lower cholesterol, and new drug combinations of existing HIV/AIDS medications that are expected to hit the market...